| Erector Spinae Block for Thoracic Surgery (NCT05521789) | George Washington University | 2022-07-22 |
| Comparison Between McGrath and Macintosh Laryngoscopes for DLT Intubation in Thoracic Surgery Patients. (NCT05988736) | Aga Khan University | 2022-06-15 |
| (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC (NCT05153408) | Blueprint Medicines Corporation | 2022-01-13 |
| mHealth ALIBIRD: A Digital Health Care Model (NCT05770869) | Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares | 2021-11-05 |
| (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC (NCT04862780) | Blueprint Medicines Corporation | 2021-06-29 |
| Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) (NCT04776447) | Fundación GECP | 2021-06-16 |
| Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma (NCT04725448) | Sichuan Cancer Hospital and Research Institute | 2021-04-06 |
| External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC (NCT04697446) | Blueprint Medicines Corporation | 2020-12-01 |
| Improving Cancer On-treatment Symptom Management (NCT04589247) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-11-16 |
| Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer (NCT04556344) | University Hospital, Lille | 2020-10-26 |
| Erector Spinae Block for Thoracoscopic Surgery (NCT04751552) | St. Antonius Hospital | 2020-10-21 |
| Role of Ultrasound Guided Peripheral Thoracic Tumors (NCT04741958) | Beni-Suef University | 2020-09-12 |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT04222972) | Hoffmann-La Roche | 2020-07-24 |
| Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC (NCT04371796) | Sichuan Cancer Hospital and Research Institute | 2020-05-10 |
| Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine (NCT04227717) | Memorial Sloan Kettering Cancer Center | 2020-01-09 |
| Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC (NCT04133337) | Sichuan Cancer Hospital and Research Institute | 2019-11-01 |
| Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC (NCT03389256) | Sichuan Cancer Hospital and Research Institute | 2018-12-30 |
| Radiotherapy Treatments for the Treatment of Thoracic District Tumors (NCT06335290) | European Institute of Oncology | 2018-02-22 |
| Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary Cancers (NCT03306693) | University Hospital, Lille | 2017-10-26 |
| A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC (NCT03134872) | Jiangsu HengRui Medicine Co., Ltd. | 2017-05-12 |
| International Lung Screen Trial (ILST) (NCT02871856) | The University of Queensland | 2017-04-05 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385) | Hoffmann-La Roche | 2017-03-17 |
| Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors (NCT02909452) | Syndax Pharmaceuticals | 2016-09-20 |
| Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors (NCT02897778) | Syndax Pharmaceuticals | 2016-08-24 |
| A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers (NCT02188563) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-05-01 |
| A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy (NCT02111824) | The Methodist Hospital Research Institute | 2014-01-05 |
| Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan (NCT01913769) | Far Eastern Memorial Hospital | 2013-07-01 |
| The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial (NCT03402048) | University of Turin, Italy | 2012-07-01 |
| Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations (NCT01024413) | Chinese Society of Lung Cancer | 2009-07-01 |
| Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer (NCT00880971) | Chinese Academy of Medical Sciences | 2009-02-18 |
| Thoracic OncoGeriatric Assessment (TOGA) Trials (NCT00591981) | University of Wisconsin, Madison | 2007-08-01 |
| Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients (NCT00437372) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2007-03-01 |
| Follow-up Modalities of Low Grade Precancerous Bronchial Lesions (NCT00213603) | University Hospital, Rouen | 2002-04-01 |
| Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury (NCT00631839) | Shanghai Cancer Hospital, China | 2002-01-01 |
| Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC (NCT06841874) | Nuvation Bio Inc. | |